J Haans

696 total citations
19 papers, 436 citations indexed

About

J Haans is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, J Haans has authored 19 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in J Haans's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (12 papers) and Gastrointestinal motility and disorders (4 papers). J Haans is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (12 papers) and Gastrointestinal motility and disorders (4 papers). J Haans collaborates with scholars based in Netherlands and United States. J Haans's co-authors include Ad Masclee, Andrea E. van der Meulen‐de Jong, Frank Hoentjen, Nanne K.H. de Boer, Gerard Dijkstra, Alexander Bodelier, Vince Biemans, Jeroen M. Jansen, Mark Löwenberg and C. Janneke van der Woude and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, American Journal of Physiology-Gastrointestinal and Liver Physiology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

J Haans

17 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Haans Netherlands 9 298 222 148 99 92 19 436
Alessandro Adriani Italy 10 93 0.3× 105 0.5× 119 0.8× 139 1.4× 132 1.4× 16 425
Heba Iskandar United States 8 208 0.7× 158 0.7× 101 0.7× 50 0.5× 90 1.0× 20 399
Suresh Pola United States 10 266 0.9× 223 1.0× 150 1.0× 41 0.4× 24 0.3× 27 386
Ayal Hirsch Israel 11 192 0.6× 144 0.6× 91 0.6× 32 0.3× 32 0.3× 51 322
Tanja Sofie Hansen Denmark 5 220 0.7× 171 0.8× 174 1.2× 45 0.5× 27 0.3× 6 409
P. Usai Italy 10 202 0.7× 524 2.4× 468 3.2× 51 0.5× 785 8.5× 18 948
Che‐Yung Chao Australia 10 249 0.8× 279 1.3× 114 0.8× 60 0.6× 61 0.7× 18 442
A. Maherzi Tunisia 10 143 0.5× 159 0.7× 234 1.6× 32 0.3× 129 1.4× 41 405
F. Colistro Italy 9 95 0.3× 129 0.6× 140 0.9× 49 0.5× 122 1.3× 14 304
Florian Poullenot France 9 130 0.4× 102 0.5× 84 0.6× 38 0.4× 52 0.6× 36 283

Countries citing papers authored by J Haans

Since Specialization
Citations

This map shows the geographic impact of J Haans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Haans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Haans more than expected).

Fields of papers citing papers by J Haans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Haans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Haans. The network helps show where J Haans may publish in the future.

Co-authorship network of co-authors of J Haans

This figure shows the co-authorship network connecting the top 25 collaborators of J Haans. A scholar is included among the top collaborators of J Haans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Haans. J Haans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Biemans, Vince, Frank Hoentjen, Nanne K.H. de Boer, et al.. (2021). Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 15(11). 1920–1930. 26 indexed citations
3.
Romberg‐Camps, Mariëlle, A Van Bodegraven, J Haans, et al.. (2021). Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial. BMJ Open. 11(5). e042885–e042885. 1 indexed citations
4.
Biemans, Vince, C. Janneke van der Woude, Gerard Dijkstra, et al.. (2020). Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment. Alimentary Pharmacology & Therapeutics. 52(1). 123–134. 76 indexed citations
5.
Biemans, Vince, Marieke Pierik, Gerard Dijkstra, et al.. (2020). Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics. 52(8). 1366–1376. 29 indexed citations
6.
Lodewick, Toine M., David P.J. van Dijk, Martijn J.L. Bours, et al.. (2020). The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease. Journal of Gastroenterology and Hepatology. 35(11). 1902–1908. 12 indexed citations
7.
Woude, J van der, Gerard Dijkstra, Andrea E. van der Meulen‐de Jong, et al.. (2020). DOP77 Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn’s disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry. Journal of Crohn s and Colitis. 14(Supplement_1). S114–S116. 1 indexed citations
8.
Biemans, Vince, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, et al.. (2019). Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 14(1). 33–45. 125 indexed citations
9.
Biemans, Vince, J van der Woude, Gerard Dijkstra, et al.. (2019). P503 Two year experience with vedolizumab in inflammatory bowel disease patients: results of the ICC case series, a nationwide prospective observational cohort study. Journal of Crohn s and Colitis. 13(Supplement_1). S363–S364. 6 indexed citations
10.
Biemans, Vince, C. Janneke van der Woude, Gerard Dijkstra, et al.. (2019). Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study. Clinical Pharmacology & Therapeutics. 107(5). 1189–1199. 25 indexed citations
11.
Biemans, Vince, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, et al.. (2018). DOP036 Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study (ICC case series). Journal of Crohn s and Colitis. 12(supplement_1). S055–S056. 1 indexed citations
12.
Romberg‐Camps, Mariëlle, A Van Bodegraven, Liekele E. Oostenbrug, et al.. (2018). DOP034 Assessment of direct healthcare cost drivers of Crohn’s disease in a Dutch population-based cohort study shows a major shift. Journal of Crohn s and Colitis. 12(supplement_1). S054–S055.
13.
Jong, Marin J. de, Andrea E. van der Meulen‐de Jong, Mariëlle Romberg‐Camps, et al.. (2018). Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study. Journal of Crohn s and Colitis. 13(4). 410–416. 32 indexed citations
14.
Jeuring, Steven, Tim van den Heuvel, Maurice P. Zeegers, et al.. (2017). [Changes in the treatment of Crohn's disease: fewer hospitalizations, less surgery, and reduced glucocorticoid use].. PubMed. 161. D1641–D1641. 2 indexed citations
15.
Haans, J, Bart van Hoek, James C.H. Hardwick, et al.. (2016). Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn’s disease. International Journal of Colorectal Disease. 32(4). 459–467. 6 indexed citations
16.
Haans, J, Paul H.C. Eilers, Johan H. C. Reiber, et al.. (2011). Gastric volume changes in response to a meal: Validation of magnetic resonance imaging versus the barostat. Journal of Magnetic Resonance Imaging. 34(3). 685–690. 8 indexed citations
17.
Haans, J & Ad Masclee. (2007). Review article: the diagnosis and management of gastroparesis. Alimentary Pharmacology & Therapeutics. 26(s2). 37–46. 23 indexed citations
18.
Haans, J & Ad Masclee. (2006). Intragastric acidification inhibits motilin‐induced phase III activity in humans. Neurogastroenterology & Motility. 18(8). 637–646. 7 indexed citations
19.
Haans, J, et al.. (2006). Gastric accommodation and motility are influenced by the barostat device: assessment with magnetic resonance imaging. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(1). G208–G214. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026